NRAS and colorectal carcinoma: These findings are in accordance with our findings on particular markers of the Rap1 axis and emphasize that factors such as NGF, FGF1, KDR, and NRAS expression, and potential molecular alterations, might be interesting to follow as potential biomarkers for metastatic CRC in future studies.